Natacha S. Ogando

22 papers receiving 1.1k citations

Peers

Natacha S. Ogando
Comparison fields: 5 of 94
  • Infectious Diseases 778
  • Molecular Biology 403
  • Animal Science and Zoology 145
  • Cardiology and Cardiovascular Medicine 107
  • Epidemiology 96
Replace Stefan van Nieuwkoop with:
Stefan van Nieuwkoop Netherlands
Ana Shulla United States
Amornrat O’Brien United States
Coralie Valle France
Muhan Huang China
Marco R. Straus United States
Robert N. Kirchdoerfer United States
Victor C. Chu United States
Thomas Kuri Germany
Natacha S. Ogando relative to Stefan van Nieuwkoop Netherlands Stefan van Nieuwkoop's profile →
Citations per field
00.5×3.1×
Stefan van Nieuwkoop · 1×
Citations per year

Countries citing papers authored by Natacha S. Ogando

Since Specialization
Citations

This map shows the geographic impact of Natacha S. Ogando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natacha S. Ogando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natacha S. Ogando more than expected).

Fields of papers citing papers by Natacha S. Ogando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natacha S. Ogando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natacha S. Ogando. The network helps show where Natacha S. Ogando may publish in the future.

Co-authorship network of co-authors of Natacha S. Ogando

This figure shows the co-authorship network connecting the top 25 collaborators of Natacha S. Ogando. A scholar is included among the top collaborators of Natacha S. Ogando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natacha S. Ogando. Natacha S. Ogando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 12
3 7
4 12
5 2
6 10
7 17
8 10
9 1
10 1
11 38
12 9
13 29
14 172
15 189
16 7
17 41
18 108
19 17
20 10

About Natacha S. Ogando

Natacha S. Ogando is a scholar working on Infectious Diseases, Animal Science and Zoology and Biological Psychiatry, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (6 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Infectious Diseases (778 citations), Animal Science and Zoology (145 citations) and Molecular Biology (403 citations). Natacha S. Ogando has collaborated with scholars based in Netherlands, Canada and France. Frequent co-authors include Eric J. Snijder, Jessika C. Zevenhoven-Dobbe, Yvonne van der Meer, Clara C. Posthuma, Peter J. Bredenbeek, Martijn J. van Hemert, Marjolein Kikkert, Julian Druce, Jutte J.C. de Vries and Leon Caly. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026